Upregulation of Surrogate Markers of Inflammation and Thrombogenesis in Patients With ESRD: Pathophysiologic and Therapeutic Implications

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Clinical and applied thrombosis/hemostasis

• Publication date

  2011-06-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1177/1076029610387127PMID 21159713
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of a single hemodialysis session on endothelial dysfunction.

  2011cited by this paper
• Oxidative stress, phosphate and creatinine levels are independently associated with vascular endothelial growth factor levels in patients with chronic renal failure.

  2008cited by this paper
• Adipokines and Gut Hormones in End-Stage Renal Disease

  2007cited by this paper
• Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor-α Gene Polymorphism in Patients with End-Stage Renal Failure

  2005cited by this paper
• Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: searching for the best risk marker by multivariate modeling.

  2005cited by this paper
• Renal Transplantation Ameliorates the Progression of Arterial Stiffness in Patients Treated with Peritoneal Dialysis

  2005influential reference
• RENAL RESEARCH INSTITUTE SYMPOSITUM: Characteristics and Effects of Inflammation in End‐Stage Renal Disease

  2003cited by this paper
• Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.

  1996cited by this paper

• Navigating through the haemostatic paradox in kidney failure: A practical overview

  2023cites this paper
• The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients

  2023cites this paper
• CD40/CD40L Signaling as a Promising Therapeutic Target for the Treatment of Renal Disease

  2020cites this paper
• Enhanced neutrophil apoptosis accompanying myeloperoxidase release during hemodialysis

  2020cites this paper
• Terminal Phase Components of the Clotting Cascade in Patients with End-Stage Renal Disease Undergoing Hemodiafiltration or Hemodialysis Treatment

  2020cites this paper
• Elevated extracellular nucleosomes and their relevance to inflammation in stage 5 chronic kidney disease.

  2018cites this paper
• Nano-Photonic Waveguides for Chemical and Biomedical Sensing

  2016cites this paper
• Inflammatory Markers and Procoagulants in Chronic Renal Disease Stages 1-4

  2015cites this paper
• Recurrent white thrombi formation in hemodialysis tubing: a case report

  2015cites this paper
• Immunoenzymatic and Biochip Array Profiling of the Biomarkers of Inflammation and Hemostatic Activation Processes in ESRD

  2015cites this paper
• The Equine PeptideAtlas: A resource for developing proteomics‐based veterinary research

  2014cites this paper
• Progressive Increase of Inflammatory Biomarkers in Chronic Kidney Disease and End-Stage Renal Disease

  2013cites this paper
• Fluid overload in hemodialysis patients: a cross-sectional study to determine its association with cardiac biomarkers and nutritional status

  2013cites this paper
• THE EFFECT OF LIFELONG MATERNAL OBESITY ON PREGNANCY OUTCOMES AND PLACENTAL DEVELOPMENT

  2012cites this paper
• Assessment of Levels of Vascular Endothelial Growth Factor in Patients With ESRD and Its Possible Role in Cardiovascular Morbidity and Mortality

  2012cites this paper